Omega-3 Fatty Acid Treatment in Multiple Sclerosis

NCT00360906 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Haukeland University Hospital

Collaborators